N-Ethylhexedrone was patented via the German pharmaceutical organization Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis along with other derivatives of aminoketone.[one] A different frequently noted home of N-ethylhexedrone is its tendency to